ArticleSurgical neurology international2025
Mucosa-associated lymphoid tissue lymphoma of the dura mimicking meningioma: A case report.
Article in Surgical neurology international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Primary central nervous system lymphomas (PCNSLs) are relatively infrequent tumors and are usually high-grade and aggressive neoplasms. A small portion of PCNSLs are low-grade lymphomas and can involve the dura. Mucosa-associated lymphoid tissue (MALT) lymphoma of the dura is an extremely rare subtype with only case reports and series documented in the literature. Case Description: A 65-year-old woman presented with a history of headaches followed by progressive left hemiparesis. Imaging studies showed an extra-axial dural-based tumor causing midline shift. Gross total resection was achieved, and the patient was discharged without postoperative complications. Histopathological examination confirmed the diagnosis of MALT lymphoma of the dura. The patient was evaluated by the oncologist and received adjuvant chemotherapy. At the 10-month follow-up, the patient experienced remission of her symptoms, and the last magnetic resonance imaging showed no evidence of tumor recurrence. Conclusion: MALT lymphoma of the dura diagnosis requires a high level of suspicion because it can often mimic meningioma. Given its rarity, there is no consensus on the standard treatment strategy. Gross total resection followed by adjuvant therapy is an accepted treatment to manage these cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.